BRIEF-Cadila Healthcare says Zydus gets USFDA approval for oxybutynin chloride extended-release tablets

Cadila Healthcare Ltd:

* Says Zydus receives final approval from USFDA for oxybutynin chloride extended-release tablets Source text for Eikon: Further company coverage:

'); $('.second-article-divide').append($('.slider.slider-module')); $('.third-article-divide').append(''); var median = (relatedItemsTotal / 2); var $relatedContentGroupOne = $('.related-content.group-one ul'); var $relatedContentGroupTwo = $('.related-content.group-two ul'); $.each($relatedItems, function(k,v) { if (k + 1 Also In Healthcare
Source: BRIEF-Cadila Healthcare says Zydus gets USFDA approval for oxybutynin chloride extended-release tablets